NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Maruti Suzuki India Reports Strong Revenue Growth, But Profitability Takes a Hit

On April 29, shares of Maruti Suzuki India rose 3.5% after the country's largest carmaker reported its March quarter results (Q4FY26). The auto stock reached a high of ₹13,350.75 per share on the BSE, driven by strong revenue growth despite pressure on profitability due to higher input costs.

Maruti Suzuki's revenue from operations for the March quarter stood at ₹52,449 crore, a 28.2% increase from ₹40,909 crore in the year-ago period. The growth was driven by steady volume growth and improved realisations, with the company selling 676,209 units during the quarter, an 11.8% increase from 604,635 units in Q4FY25.

However, net profit declined 7% YoY to ₹3,591 crore, as elevated raw material and operating costs weighed on earnings. Total expenses rose sharply to ₹48,113 crore compared with ₹37,576 crore a year ago, reflecting higher steel, aluminium, and freight costs.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

QuarterRevenueNet ProfitEBITDA
Q4FY25₹40,909 crore₹3,857 crore₹4,830 crore
Q4FY26₹52,449 crore₹3,591 crore₹6,156 crore

Maruti Suzuki's EBITDA margin remained largely flat at 11.7%, while EBITDA increased 27.1% YoY to ₹6,156 crore. The company reported revenue of ₹1,74,369.5 crore for the full year FY26, up 20.2% YoY, and net profit of ₹14,445.4 crore, marking a record high.

The company also announced a final dividend of ₹140 per share for FY26, with the record date set for Wednesday, July 7, and the payout to be made on Wednesday, September 9.

In recent times, Maruti Suzuki's stock has been volatile, gaining 4% in 1 month but losing 13% in 3 months. The scrip hit its record high of ₹17,371.60 in January 2026 and its 52-week low of ₹11,332.05 in April 2025.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Brokerage house Motilal Oswal reiterated its BUY rating with a target price of ₹15,529, citing the company's strong order backlog and healthy new launch pipeline. Choice Broking maintained an 'add' rating for the stock but cut its target price to ₹14,600 from ₹16,200 earlier.

Investor Takeaway

Investors should focus on the company's revenue growth and volume expansion despite pressure on profitability due to higher input costs.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.